Iovance Biotherapeutics Inc Working Capital to Net Assets Ratio
Iovance Biotherapeutics Inc working capital to net assets ratio. Iovance Biotherapeutics Inc (IOVA) has a Working Capital to Net Assets ratio of 43.2% as of September 2025. Working capital of $303.31 Million (current assets of $429.09 Million minus current liabilities of $125.78 Million) is measured against net assets of $702.29 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check how tangible is Iovance Biotherapeutics Inc's equity to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Iovance Biotherapeutics Inc (2008–2024)
Working capital to net assets ratio of Iovance Biotherapeutics Inc from 2008 to 2024. This chart shows how Iovance Biotherapeutics Inc's Working Capital to Net Assets ratio has evolved across 17 annual periods from 2008 to 2024. As of September 2025, the ratio stands at 43.2%, reflecting working capital of $303.31 Million against net assets of $702.29 Million USD. See Iovance Biotherapeutics Inc (IOVA) defensive interval to measure how many days the company can operate on defensive assets alone.
Iovance Biotherapeutics Inc Working Capital to Net Assets Ratio by Year (2008–2024)
Iovance Biotherapeutics Inc working capital to net assets ratio by year from 2008 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Iovance Biotherapeutics Inc from 2008 to 2024, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see IOVA current and non-current assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 47.1% | $334.68 Million | $710.40 Million | $457.02 Million | $122.34 Million | ▲ +13.3 pp |
| 2023 | 33.8% | $197.54 Million | $584.61 Million | $307.85 Million | $110.31 Million | ▼ -43.8 pp |
| 2022 | 77.6% | $387.63 Million | $499.64 Million | $479.12 Million | $91.48 Million | ▲ +10.2 pp |
| 2021 | 67.4% | $418.76 Million | $621.66 Million | $507.96 Million | $89.20 Million | ▼ -21.2 pp |
| 2020 | 88.5% | $581.23 Million | $656.50 Million | $636.10 Million | $54.87 Million | ▼ -4.3 pp |
| 2019 | 92.8% | $277.41 Million | $298.97 Million | $316.49 Million | $39.08 Million | ▼ -6.1 pp |
| 2018 | 98.9% | $460.98 Million | $466.19 Million | $475.37 Million | $14.40 Million | ▲ +3.1 pp |
| 2017 | 95.8% | $139.40 Million | $145.48 Million | $149.29 Million | $9.89 Million | ▼ -2.8 pp |
| 2016 | 98.6% | $164.54 Million | $166.92 Million | $169.51 Million | $4.97 Million | ▲ +0.2 pp |
| 2015 | 98.4% | $102.35 Million | $104.02 Million | $103.98 Million | $1.63 Million | ▲ +1.8 pp |
| 2014 | 96.6% | $43.31 Million | $44.85 Million | $44.98 Million | $1.66 Million | ▼ -3.3 pp |
| 2013 | 99.8% | $17.58 Million | $17.60 Million | $19.85 Million | $2.27 Million | ▼ -0.4 pp |
| 2012 | 100.2% | $-11.34 Million | $-11.32 Million | $7.28K | $11.35 Million | ▼ -0.2 pp |
| 2011 | 100.3% | $-12.83 Million | $-12.78 Million | $524.08K | $13.35 Million | ▲ +25.4 pp |
| 2010 | 74.9% | $478.05K | $638.09K | $1.30 Million | $822.87K | ▼ -34.2 pp |
| 2009 | 109.1% | $-14.71K | $-13.49K | $8.41K | $23.12K | ▲ +121.0 pp |
| 2008 | -12.0% | $-273.00 | $2.28K | $3.06K | $3.33K | — |